Pharmacist prescribing continues to be a key area for advocacy, especially with the onset of the COVID-19 pandemic. This podcast episode highlights a rural health system’s model to empower pharmacist prescribing of COVID-19 oral antiviral medications and addresses challenges in providing optimal patient care in the small and rural hospital setting.    

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode discusses social determinants of health in pharmacy practice and training. The speakers address the significance of social determinants of health in patient care as well as the importance of introducing these principles early in pharmacy education.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Medications utilized in rapid sequence intubation vary in preference and dosing in special populations. This podcast episode focuses on RSI in obese patients.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

As SGLT2-inhibitors become more relevant in multiple disease states with recent data surrounding HFpEF, we will discuss the real world implementation of the medication. We will also review how cost and formularies may affect our decision. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

From the 2021 Midyear Clinical Meeting and planned in cooperation with Section of Ambulatory Care Practitioners, this session explores the current status of COVID-19 vaccines in the United States, summarizes the ideal pharmacist role in immunization delivery and how to overcome barriers to COVID-19 administration.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This podcast episode highlights a unique and innovative virtual shadowing program for pre-health students developed by the University of Florida Department of Neurology. Members of the ASHP New Practitioners Forum chat with founders of the Medi-Gators Virtual Shadowing Program to gather their insights and lessons learned when developing the program to improve access to shadowing, mentorship, and other health-related opportunities for all students. Learn more about the Medi-Gators Virtual Shadowing Program here: https://neurology.ufl.edu/divisions/neurocritical-care/medi-gators-virtual-shadowing-program/ 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Hear experts discuss the FDA’s recent Complete Response Letter CRL regarding Takeda’s budesonide oral solution for eosinophilic esophagitis (EoE), what therapies are in the pipeline for EoE and their potential role in therapy. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Intensive care unit (ICU) delirium is a common and severe manifestation of critical illness. It can occur in up to 80% of mechanically ventilated ICU patients and leads to longer lengths of stay and increases the risk of mortality. The etiology of ICU delirium is not well-elucidated, making pharmacological treatments difficult to target. This podcast will discuss the risk factors, definitions, and treatment of ICU delirium.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In this podcast episode, Doug Scheckelhoff, Dr. Chuck Daniels, and Lynnae Mahaney discuss the ASHP Standard for Certification as a Center of Excellence in Medication-Use Safety and Pharmacy Practice, with host and AJHP Editor in Chief Dr. Daniel Cobaugh.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

From the 2021 Midyear Clinical Meetings, researchers with the support of the ASHP Foundation share the preliminary results of their ongoing study that looks at satisfaction levels of pharmacy technicians working in ambulatory care. Their research is also seeking to obtain a deeper understanding of variation in the roles of pharmacy technicians in the ambulatory care setting and explore factors influencing job satisfaction and dissatisfaction.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.